| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |